# Once Daily Given Alfuzosin in the Treatment of BPH

> **NCT00637715** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 60 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** Alfuzosin

## Key facts

- **NCT ID:** NCT00637715
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2008-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637715, "Once Daily Given Alfuzosin in the Treatment of BPH". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00637715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*